Integer Q3 sales up 8% to $468 million; GAAP diluted EPS rises 10% to $1.11
Integer Holdings reported third-quarter 2025 sales of $468 million, up 8%, and GAAP diluted EPS from continuing operations of $1.11, up from $1.01. Nine-month GAAP income from continuing operations fell 38.4%, reflecting a $46.7 million debt conversion inducement expense, and the company gave a preliminary 2026 outlook for reported sales of down 2% to up 2%.
Key points
- Q3 sales were $468 million, up 8%, with organic growth of 7%; Cardio & Vascular sales rose 15%.
- Q3 adjusted EPS was $1.79, up 25%; GAAP diluted EPS was $1.11, up 10%.
- Nine-month GAAP income from continuing operations was $54.2 million, down 38.4%, including $46.7 million of debt conversion inducement expense.
- Total debt was $1.194 billion as of September 26, 2025, a leverage ratio of 3.0 times adjusted EBITDA; preliminary 2026 adjusted EPS outlook is down 6% to up 5%.
The filing
Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 23, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.